Zhi-Wei Chen

Zhi-Wei Chen

Auto-generated profile, based on publicly available information

Zhi-Wei Chen

Institute of Neuroscience, Kunming Medical University, Kunming, Yunnan Province, China; Key Laboratory of National Physical Fitness and Altitude Training Adaptation in Yunnan Province, Institute of Physical Education, Yunnan Normal University, Kunming, Yunnan 650000, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2014 in International Immunopharmacology
Verified
Journal Article
Closed access
ZSZu-Qing Su
Zu-Qing Su
ZMZhi-Zhun Mo
Zhi-Zhun Mo
JLJin-Bin Liao
Jin-Bin Liao
XFXue-Xuan Feng
Xue-Xuan Feng
YLYong-Zhuo Liang
Yong-Zhuo Liang
XLXiaoping Lai
Xiaoping Lai

1 January 2014 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
XWXioali Wu
Xioali Wu
XFXue-Xuan Feng
Xue-Xuan Feng
CLChuwen Li
Chuwen Li
XZXiaojun Zhang
Xiaojun Zhang
ZCZhi-Wei Chen
Zhi-Wei Chen
ZSZi-ren Su
Zi-ren Su
The supercritical-carbon dioxide fluid extract ofChrysanthemum indicumLinné. (CFE) has been demonstrated to be effective in suppressing inflammation. The aim of this study is to investigate the preventive action and underlying mechanisms of CFE on acute lung injury (ALI) induced by lipopolysaccharide (LPS) in mice. ALI was induced by intratracheal instillation of LPS into lung, and dexamethasone was used as a positive control. Results revealed that pretreatment with CFE abated LPS-induced lung histopathologic changes, reduced the wet/dry ratio and proinflammatory cytokines productions (TNF-α, IL-1β, and IL-6), inhibited inflammatory cells migrations and protein leakages, suppressed the levels of MPO and MDA, and upregulated the abilities of antioxidative enzymes (SOD, CAT, and GPx). Furthermore, the pretreatment with CFE downregulated the activations of NF-κB and the expressions of TLR4/MyD88. These results suggested that CFE exerted potential protective effects against LPS-induced ALI in mice and was a potential therapeutic drug for ALI. Its mechanisms were at least partially associated with the modulations of TLR4 signaling pathways.

1 April 2017 in Brain Research
Verified
Journal Article
Closed access
LJLing Jiang
Ling Jiang
QXQing-Jie Xia
Qing-Jie Xia
XDXiu-Juan Dong
Xiu-Juan Dong
YHYue Hu
Yue Hu
ZCZhi-Wei Chen
Zhi-Wei Chen
TWTing-Hua Wang
Ting-Hua Wang

1 May 2016 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
JXJian-Hui Xie
Jian-Hui Xie
ZCZhi-Wei Chen
Zhi-Wei Chen
YPYa-Wei Pan
Ya-Wei Pan
DLDe-Min Luo
De-Min Luo
ZSZi-Ren Su
Zi-Ren Su
GLGao Lei
Gao Lei

1 January 2015 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
CLChu-Wen Li
Chu-Wen Li
ZCZhi-Wei Chen
Zhi-Wei Chen
XWXiao-Li Wu
Xiao-Li Wu
ZNZhao-Xiao Ning
Zhao-Xiao Ning
ZSZu-Qing Su
Zu-Qing Su
XLXiao-Ping Lai
Xiao-Ping Lai
A standardized traditional Chinese medicine preparation named Yejuhua capsule (YJH) has been clinically used in treatments of various acute respiratory system diseases with high efficacy and low toxicity. In this study, we were aiming to evaluate potential effects and to elucidate underlying mechanisms of YJH against lipopolysaccharide- (LPS-) induced acute lung injury (ALI) in mice. Moreover, the chemical analysis and chromatographic fingerprint study were performed for quality evaluation and control of this drug. ALI was induced by intratracheal instillation of LPS (5 mg/kg) into the lung in mice and dexamethasone (5 mg/kg, p.o.) was used as a positive control drug. Results demonstrated that pretreatments with YJH (85, 170, and 340 mg/kg, p.o.) effectively abated LPS-induced histopathologic changes, attenuated the vascular permeability enhancement and edema, inhibited inflammatory cells migrations and protein leakages, suppressed the ability of myeloperoxidase, declined proinflammatory cytokines productions, and downregulated activations of nuclear factor-κB (NF-κB) and expressions of toll-like receptor 4 (TLR4). This study demonstrated that YJH exerted potential protective effects against LPS-induced ALI in mice and supported that YJH was a potential therapeutic drug for ALI in clinic. And its mechanisms were at least partially associated with downregulations of TLR4/NF-κB pathways.